Seed funding for novel, high-risk, high-reward translational research to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging.
Up to $200,000 over up to 18 months
Principal applicants must be at or above the level of postdoctoral researcher at a CRA qualified institution located in Canada.
Project must involve the development of a therapeutic, and/or a tool to help accelerate the development of therapeutics for neurodegenerative diseases of aging
This program is run through alternating calls that are disease focused.
Parkinson’s & Related Diseases:
- PD, PSP, LBD, MSA, prodromes, and vascular contributions to the listed diseases
- Launch: Currently open
Alzheimer’s & Related Diseases:
- AD, FTD, MCIprodromes, and vascular contributions to the listed diseases
- Launch: November 2017
Letter of Intent Deadline: December 4, 2017 at 2pm EST
Program Information Session: October 10, 2017 at 1pm EDT (Register here)